CHEMICAL/BIOLOGICAL DEFENSE (ATD)

Abstract

This program element (PE) demonstrates technologies that enhance the ability of U.S. forces to deter, defend against, and survive Chemical, Biological, and Radiological (CBR) warfare. The PE funds advanced technology development for Joint Service and Service-specific requirements in both medical and physical sciences CBR defense areas. The medical program (was TB3, TC3, TR3, but in FY13 these continue within one project, TM3), aims to produce biological diagnostic assays and reagents, diagnostic device platforms, pretreatments and therapeutics for bacterial, viral, and toxin threats as well as for chemical threats, and medical devices, as countermeasures for CBR threat agents. Specific areas of medical investigation include: prophylaxis, pretreatment, antidotes and therapeutics, personnel and patient decontamination, and medical management of casualties. In the physical sciences area (CB3), the focus is on demonstrations of CB defense technologies, including biological detection, chemical detection, information system technology for hazard prediction and systems performance, and protection, and decontamination. NT3 consolidated all efforts related to non-traditional agents (NTAs), including NTA chemical diagnostics, medical pretreatments, therapeutics, detection, and protection and hazard mitigation. The PE also provides for the conduct of advanced technology development in the areas of real-time sensing, accelerated biological warfare operational awareness, and the restoration of operations following a biological warfare or chemical warfare attack (project TT3). The PE is dedicated to conducting proof-of-principle field demonstrations, and testing system-specific technologies to meet specific military needs. Work conducted under this PE will transition to and will provide risk reduction for System Integration/Demonstration (PE 0603884BP/PE 0604384BP) activities. Key efforts within this PE are in support of the FY14 policy priorities for Countering Biological Threats. Approximately $71.9M supports the priority to "Promote global health security efforts through building and improving international capacity to prevent, detect, and respond to infectious disease threats, whether caused by natural, accidental, or deliberate events." Approximately $60.0M supports the priority to "Expand our capability to prevent, attribute, and apprehend those engaged in biological weapons proliferation or terrorism, with a focus on facilitating data sharing and knowledge discovery to improve integrated capabilities." Approximately $75.4M supports the priority to "Leverage science, technology, and innovation through domestic and international partnerships and agreements to improve global capacity to respond to and recover from biological incidents." To recap, in FY13, all traditional agent Medical Biological and Medical Chemical Defense efforts (Projects TB3 and TC3) were re-aligned to Project TM3 - Techbase Medical Defense (ATD). CB3 Advanced Technology Development efforts continue to pursue solutions against traditional agents. All non-traditional agent (NTA)-dedicated research (both medical and non-medical) was re-aligned to Project NT3 - Techbase Non-Traditional Agents Defense (ATD). Project TT3, Techbase Technology Transition, pursues efforts to enhance military operational capability, concepts of operation, WMD elimination, and hazard mitigation following a biological warfare or chemical warfare attack.

Open PDF

Document Details

Document Type
R2 Budgetary Justification
Publication Date
Oct 01, 2014
Source ID
0603384BP_3_0400_PB_2014
Change Summary Explanation
Funding: FY14 -$49.759M Other Adjustments (CB3 -$252K; NT3 -$7,531K; TM3 -$48,682K; TT3 +$6,706K) Schedule: N/A Technical: N/A
Service Agency Name
Chemical and Biological Defense Program

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Chemical Warfare
  • Chemical Warfare Agents
  • Chemistry
  • Data Analysis
  • Detection
  • Disease Outbreaks
  • Equine Encephalitis
  • Health Services
  • Infectious Diseases
  • Information Systems
  • Medical Personnel
  • Nerve Agents
  • Small Molecules
  • Test And Evaluation
  • Therapy
  • Vaccines
  • Viruses

Readers

  • Critical Infrastructure Protection in CBRN and WMD Threats.
  • Military Science and Technology Research and Modernization.

Related Documents